Experimental study on the relation between the noninvasive ultrasonography quantitative scoring system and the degree of the hepatic fibrosis

Hepato-Gastroenterology

Volumn 54, Issue 79, 2007, Pages 1908-1914

  Yan, Guozhen ^a   Duan, Yunyou ^a   Ruan, Litao ^a   Yang, YiLin ^a   Cao, TieSheng ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Hepatic fibrosis; Pathological diagnosis; Scoring system; Ultrasonography diagnosis

Indexed keywords

BIOLOGICAL MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; EXPERIMENTAL STUDY; HISTOPATHOLOGY; LIVER FIBROSIS; MALE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY;

ANIMALS; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, SPRAGUE-DAWLEY; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 37749001172     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Mai W, Barraud L, Lefrancois L, et al: Ultrasonography detection of spontaneous hepatocellular carcinomas in X/myc bitransgenic mice. Liver Internat 2004; 24:651-657.
2. Hepatic fibrosis study group of Chinese liver diseases: Consensus on evaluation of the diagnosis and efficacy of hepatic fibrosis. Chin J Hepatol 2002; 10(5):327-328.
3. Lu Lungen, Zeng Minde, Wan Mobin, et al: Grading and staging of hepatic fibrosis and its relationship with noninvasive diagnostic parameters. World J Gastroenterol 2003; 9(11):2574-2578.
4. Zheng Rongqin, Wang Qinghui, Lu Mingde, et al: Liver fibrosis in chronic viral hepatitis: An Ultrasonographic study. World J Gastroenterol 2003; 9(11):2584-2489.
5. Aube C, Oberbi F, Korali N, et al: Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis. J Hepatol 1999; 30:472-478.
6. Oinzani M, Rombouts K: Liver fibrosis: from the bench to clinical targets. Dig Liver Dis 2004; 4(36):231-242.
7. Croquet V, Moal F, Veal N, et al: Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and/or portal hypertension. J Hepatol 2002; 37:773-780.
8. Wenchun Y, Paichi L, Yungming J, et al: Elastic modulus measurement of human liver and correlation with pathology. Ultrasonog Med Biol 2002; 28(4):467-474.
9. Hamato N, Moriyasa F, Someda H, et al: Clinical applications of hepatic venous hemodynamics by Doppler Ultrasonography in chronic liver disease. Ultrasonog Med Biol 1997; 23(6):829-835.
10. Hidetsugu Saito, Shinichiro Tada, Nobuhiro Nakamoto, et al: Efficacy of non-invasive elastometry on staging of hepatic fibrosis . Hepatol Res 2004; 2(29):97-103.
11. Pinzani K: Rombouts. Liver fibrosis: from the bench to clinical targets. Dig Liver Dis 2004; 4(36):231-242.
12. Massarrat S, Fallahazad V, Kamalian N: Clinical, biochemical and imaging-verified regression of hepatitis B-induced cirrhosis. Liver Internat 2004; 24:105-109.
13. Saudeh S, Younossi ZM, Remer EM, et al: The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123(3):745-750.
14. Joy D, Thava VR, Scott BB: Diagnosis of fatty liver disease: is biopsy necessary? Eur J Gastroenterol 2003; 15(5):539-543.
15. Vitellas KM, Tzalonikon MT, Bennett WF, et al: Cirrhosis: spectrum of finding on unenhanced and dynamic gadolinium enhanced MR imaging. Abdom Imaging 2001; 26:601-615.
16. Katranci N, Elmas N, Yilmaz F, et al: Correlative CT, MRI, and histological findings of hepatic echinococcus alveolaris: a case report. Comput Med Imag Graph 1999; 23:159-159.